LATEST DISCOUNTS & SALES: PROMOTIONS

Close Notification

Your cart does not contain any items

$378.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Academic Press Inc
30 October 2020
The PCP's Bicentennial Edition

Remington: The Science and Practice of Pharmacy, Twenty Third Edition, offers a trusted, completely updated source of information for education, training, and development of pharmacists. Published for the first time with Elsevier, this edition includes coverage of biologics and biosimilars as uses of those therapeutics have increased substantially since the previous edition. Also discussed are formulations, drug delivery (including prodrugs, salts, polymorphism. With clear, detailed color illustrations, fundamental information on a range of pharmaceutical science areas, and information on new developments in industry, pharmaceutical industry scientists, especially those involved in drug discovery and development will find this edition of Remington an essential reference. Intellectual property professionals will also find this reference helpful to cite in patents and resulting litigations. Additional graduate and postgraduate students in Pharmacy and Pharmaceutical Sciences will refer to this book in courses dealing with medicinal chemistry and pharmaceutics.

Edited by:  
Imprint:   Academic Press Inc
Country of Publication:   United States
Edition:   23rd edition
Dimensions:   Height: 276mm,  Width: 215mm, 
Weight:   2.970kg
ISBN:   9780128200070
ISBN 10:   0128200073
Pages:   1030
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active
Section 1: Introduction Section 2: Natural Products Section 3: Pharmaceutical Chemistry Section 4: Pharmacokinetics/Pharmacodynamics Section 5: Pharmaceutics Section 6: Biopharmaceutics Section 7: Pharmaceutical Materials and Devices/Industrial Pharmacy Section 8: Translational Research Section 9: Pharmacy Practice Section 10: Pharmaceutical Outcomes and Policy

Adeboye Adejare’s research group is interested in the areas of design and syntheses of small organic molecules to probe neurodegeneration, especially Alzheimer’s disease, and for treatment of cancer. They are also interested in in vitro models of drug absorption and ability to cross blood brain barrier; drug targeting; pharmaceutical profiling; and chemistry of fluoroaromatic compounds. The research is funded by the National Institutes of Health, the Office of Naval Research, and several pharmaceutical companies. These efforts have resulted in over 50 publications, 5 patents, and over 100 presentations at meetings, including invited presentations at national and international conferences. He also serves on several national panels, including those by NIH, NSF, and Alzheimer’s Association. Dr. Adejare is the editor of Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer’s Disease which is also published by Elsevier.

Reviews for Remington: The Science and Practice of Pharmacy

"""In the foreword, the editor-in-chief recognizes the breadth of topics that the title seeks to address and notes that this title, in its entirety, may not be needed by all learners and practitioners. That being said, there is no better reference than this title as a base reference/learning resource for pharmaceutics/pharmaceutical applications with further information on which to build for clinical application and knowledge."" --Doody"


See Also